MONTREAL, April 1, 2019 (GLOBE NEWSWIRE) – I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, proudly announces its 30-year anniversary providing OSD solutions to the global eye care community. I-MED Pharma dates-back to April of 1989, when Dr. Ilan Hofmann, PhD, BSc in biochemistry, and Maureen Blanchard opened a small […]
MONTREAL, March 26, 2019 (GLOBE NEWSWIRE) – I-MED Pharma, Inc., a Canadian company specializing in dry eye diagnosis and management, announced today the signing of an exclusive agreement with DryCom -Dry Eye Solutions for distribution of its I-PEN® Tear Osmolarity System in Brazil. The I-PEN® is the world’s first, point-of-care, electronic diagnostic testing device to detect […]
I-MED Pharma Partners with Simovision to Bring the I-PEN® Osmolarity System to Belgium, Luxembourg & the Netherlands MONTREAL, October 2, 2018 (GLOBE NEWSWIRE) – I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, is pleased to announce the signing of an exclusive agreement with Simovision for distribution rights in the Benelux […]
West Island businesses get financial boost from Quebec Government The Quebec government is giving several West Island companies a financial boost. A total of $443,103 has been distributed to help finance four export and 10 research and development initiatives. The money will help absorb export costs, patent costs and salaries for new hires, among other […]
MONTREAL, July 23, 2018 (GLOBE NEWSWIRE) – I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, is pleased to announce the signing of an exclusive agreement with Medicals International for distribution rights in the Middle East for its patented I-PEN® Tear Osmolarity System. The I-PEN® Osmolarity System is the world’s first, […]
Montreal, May 24, 2018 (Globe Newswire) – I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, is pleased to announce the signing of a Canadian distribution agreement with ESW Vision for the patented E>Eye device. E>Eye, designed and manufactured in France by E-Swin, is the first and only CE certified medical […]
Montreal, April 3, 2018 (Globe Newswire) – I-MED Pharma Inc., a Canadian Company specializing in dry eye diagnosis and management, is pleased to announce receiving regulatory approval from INVIMA in Colombia and ANMAT in Argentina for its patented I-PEN® Osmolarity System. The I-PEN® Osmolarity System is the world’s first handheld platform that offers eye care […]
Montreal, January 8, 2018 (Globe Newswire) – I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, is pleased to announce the signing of an exclusive agreement with OCuSOFT Inc. for distribution rights in the United States for its patented I-PEN® Osmolarity System. On December 22, 2017 the FDA issued an Acceptance […]
MONTREAL, January 8, 2018 (GLOBE NEWSWIRE) – I-MED Pharma, Inc., a Canadian company specializing in dry eye diagnosis and management, announced today the signing of an exclusive agreement with IMEX for distribution of its I-PEN® Tear Osmolarity System and I-PLUG® punctum plugs for Spain and Portugal. Daniel Hofmann, President of I-MED Pharma said, “IMEX is a promising […]